Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

F Thomas Kaplan

Hand Surgery Indianapolis, IN Medical Doctor

NPI 1588673404 CMS profile 253005

8501 Harcourt Rd, Indianapolis, IN 46260

Open in the dashboard

General payments

$6,896

110 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$33,995 paid to institutions, not to them · program years 2021–2023

Through program year 2025, F Thomas Kaplan of Indianapolis, IN is reported in the CMS Open Payments database as having received $6,896 across 110 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $33,995 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 72nd percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,229 13
2024 General $844 12
2023 General $511 7
2022 General $1,451 36
2021 General $908 14
2020 General $768 13
2019 General $1,184 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • F Thomas Kaplan
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to F Thomas Kaplan were reported at $1,229. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year F Thomas Kaplan Hand Surgery median Middle half National median
2019 $1,184 $383 $106–$1,905 $163
2020 $768 $172 $51–$1,268 $114
2021 $908 $263 $71–$1,591 $132
2022 $1,451 $336 $87–$1,938 $149
2023 $511 $233 $81–$1,114 $160
2024 $844 $258 $88–$1,203 $164
2025 $1,229 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $1,019 16 payments
  2. Acumed LLC $617 12 payments
  3. Integra LifeSciences Corporation $544 6 payments
  4. AxoGen $502 4 payments
  5. Trice Medical, Inc. $372 2 payments
  6. Sonex Health, Inc. $295 21 payments
  7. ExsoMed Corporation $293 1 payment
  8. Encore Medical, LP $291 4 payments
  9. Medartis Inc. $286 3 payments
  10. Djo, LLC $251 5 payments
  11. Other $2,426 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,419 87 payments
  2. Long term medical supply or device loan $295 21 payments
  3. Education $182 2 payments
Products named General payments · program years 2019–2025
  1. ACUMED $486 10 payments
  2. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $473 10 payments
  3. INnate Implant $437 9 payments
  4. XIAFLEX $391 10 payments
  5. PRIMATRIX $350 3 payments
  6. INTEGRA DERMAL REGENERATION TEMPLATE $350 3 payments
  7. ULTRAGUIDECTR $295 21 payments
  8. ULTRAGUIDETFR $295 21 payments
  9. Integra Recon-Skin And Wound $227 2 payments
  10. Integra Recon-Skin And Wound $227 2 payments
  11. Other $6,053 81 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 110 billing codes

Paid by Medicare

$247,925

Of which drugs: $68,571

Medicare patients

588

Average age 73

Services billed

3,782

365 women, 223 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 65%
Ischemic heart disease 29%
Diabetes 28%
Depression 27%
Chronic kidney disease 20%
Osteoporosis 20%
Cancer 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 186 555 $2,947

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XIAFLEX
  • Endo USA, Inc. $151
$151 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

110 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record